Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05412433 · ClinicalTrials.gov registry record · NA
Clinic-based HIV Identification and Prevention Project Using Electronic Resources
A NA study of HIV Prevention and PrEP, sponsored by Johns Hopkins University.
- Active
- Registry status
- NA
- Development phase
- 1,170
- Enrollment target
- 1
- Study location
NCT05412433: Active NA study of HIV Prevention and PrEP, sponsored by Johns Hopkins University.
NCT05412433 is a NA study of HIV Prevention and PrEP that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 1,170 participants, above the 345-participant average among 32 other HIV Prevention trials with a reported enrollment target (239% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05412433, a NA study of HIV Prevention and PrEP, is active but no longer recruiting, sponsored by Johns Hopkins University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,170 participants
- Enrollment target
- 1
- Study location
Study Summary
Hybrid Type II effectiveness-implementation trial to investigate whether electronic medical and sexual history data collection with HIV risk categorization/scoring will increase pre-exposure prophylaxis (PrEP) uptake among cis-gender women attending routine well-woman gynecologic preventative visits.
Primary Outcome
Number of PrEP prescriptions written for each patient up to 4 weeks after office visit.
Conditions Studied
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Patient Level
- BEHAVIORAL Multilevel
Study Locations (1)
Maryland
- Johns Hopkins Health System - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,170 participants |
| Start Date | 2022-10-03 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What the registry record for NCT05412433 still lists
NCT05412433 is an interventional study that assigns participants to a tested intervention. Its 1,170 participants enrollment target places it among the larger protocols in the corpus, above the 345-participant average among 32 other HIV Prevention trials with a reported enrollment target (239% higher).
The record links to 3 conditions, with HIV Prevention appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.
NCT05412433 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT05412433 about?
NCT05412433 is a clinical study titled "Clinic-based HIV Identification and Prevention Project Using Electronic Resources". Hybrid Type II effectiveness-implementation trial to investigate whether electronic medical and sexual history data collection with HIV risk categorization/scoring will increase pre-exposure prophylaxis (PrEP) uptake among cis-gender women attending routine well-woman gynecologic preventative visits...
What is the current status of trial NCT05412433?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,170 participants. The study started on 2022-10-03. Estimated completion is 2027-12-31.
What conditions does trial NCT05412433 study?
This clinical trial studies the following conditions: HIV Prevention, PrEP, Primary Care.
What interventions are being tested in trial NCT05412433?
The interventions under investigation include: Control (BEHAVIORAL), Patient Level (BEHAVIORAL), Multilevel (BEHAVIORAL).
Who is sponsoring clinical trial NCT05412433?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05412433 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Prevention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05412433's enrollment target sits among peer trials
1,170 2nd of 32 the highest of 32 other HIV Prevention trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Prevention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Using PrEP, Doing It for Ourselves
RECRUITING · NA
-
Client-Centered Care Coordination for Black Men Who Have Sex With Men
RECRUITING · NA
-
Behavioral Economic Intervention to Improve HIV Behaviors in Sexual Minority Individuals
RECRUITING · NA
-
Intervention to Enhance PrEP Persistence
RECRUITING · NA
-
WePrEP: Developing a PrEP Shared Decision-making Tool for Transgender Women
RECRUITING · NA
-
Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06469788 · 1,170 participants · NA
Testimonials and Navigation in Rheumatology
- NCT04275557 · 1,174 participants
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
- NCT07009509 · 1,166 participants · NA
Pilot Study of the YES-CAN! Program to Prevent Youth Nicotine Vaping
- NCT06133322 · 1,176 participants · NA
Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI